Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Villafana stands down as ATS CEO (Chief Executive Officer) for new company

This article was originally published in Clinica

  • News

Executive Summary

Manny Villafana, chairman and CEO of heart valve company ATS Medical, is to step down as CEO at the end of the year. The entrepreneur is leaving the company, where he spent 11 years, to spend more time at CABG Medical, a development-stage company he began around a year ago. CABG has developed a technique for performing cardiovascular surgery using an artificial coronary graft.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Medtronic Adds AI In Reveal Linq Device To Reduce False Alerts

Shuren: CDRH Needs More Funding For Active Surveillance, Supply Chain Monitoring

EU Medical Professions Call For Immediate Measures To Prevent Device Shortages

New China Tariffs Include Higher Rates For Syringes, PPE

See All
UsernamePublicRestriction

Register

MT073923

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By